SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the March 2024 quarter moved down to Rs. 2994.30 millions as compared to Rs. 3806.20 millions during the year-ago period.The Net Loss for the quarter ended March 2024 is Rs. -2564.00 millions as compared to Net Profit of Rs. 64.60 millions of corresponding quarter ended March 2023The Operating Profit of the company witnessed a decrease to 114.30 millions from 566.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 2994.30 3806.20 -21.33 12889.20 14438.10 -10.73 12889.20 14438.10 -10.73
Other Income 16.30 51.20 -68.16 53.70 221.40 -75.75 53.70 221.40 -75.75
PBIDT 114.30 566.70 -79.83 -896.90 1561.80 -157.43 -896.90 1561.80 -157.43
Interest 306.20 219.60 39.44 1059.70 900.60 17.67 1059.70 900.60 17.67
PBDT -1425.10 347.10 -510.57 -3853.00 661.20 -682.73 -3853.00 661.20 -682.73
Depreciation 251.00 264.00 -4.92 1030.30 1109.00 -7.10 1030.30 1109.00 -7.10
PBT -1676.10 83.10 -2116.97 -4883.30 -447.80 990.51 -4883.30 -447.80 990.51
TAX 887.90 18.50 4699.46 785.40 -225.70 -447.98 785.40 -225.70 -447.98
Deferred Tax 887.90 18.50 4699.46 785.40 -224.60 -449.69 785.40 -224.60 -449.69
PAT -2564.00 64.60 -4069.04 -5668.70 -222.10 2452.32 -5668.70 -222.10 2452.32
Equity 360.00 360.00 0.00 360.00 360.00 0.00 360.00 360.00 0.00
PBIDTM(%) 3.82 14.89 -74.36 -6.96 10.82 -164.33 -6.96 10.82 -164.33

Solara Active Pharma Share Price

499.25 9.95 (2.03%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×